The Netherlands: VectorY appoints Wyzga as CFO adds Franchi to board

VectorY Therapeutics, a biotech company developing disease-modifying vectorized antibody therapies for the treatment of neurodegenerative diseases, has appointed Michael Wyzga as CFO. Wyzga most recently served as CFO of Yumanity Therapeutics, a Nasdaq-listed clinical stage biopharmaceutical company, where he managed the sale of assets to Janssen Phamaceutica, part of J&J, and a merger with Kineta….